Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00375024 · ClinicalTrials.gov registry record · NA

Patient Navigator Project

A NA study of Breast Cancer and Colon Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
NA
Development phase
1,267
Enrollment target
1
Study location

NCT00375024: Completed NA study of Breast Cancer and Colon Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NCT00375024 is a NA study of Breast Cancer and Colon Cancer that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 1,267 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00375024, a NA study of Breast Cancer and Colon Cancer, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
NA
Development phase
1,267 participants
Enrollment target
1
Study location

Study Summary

Patient Navigation is a Supportive Care Intervention that addresses barriers to quality standard care by providing individualized assistance to patients and families. The NCI is conducting several research programs to test the effectiveness of this approach. The expected outcomes of patient navigation through the cancer care system include: * Timely, definitive diagnosis following an abnormal test * Timely treatment following positive diagnosis * Patient satisfaction with the diagnostic and care system experience

Primary Outcome

Time from finding of abnormality to definitive diagnosis

Interventions

  • PROCEDURE Patient Navigation
  • PROCEDURE Clinic Staff

Study Locations (1)

Florida

  • H. Lee Moffitt Cancer Center & Research Institute - Tampa

Trial Details

FieldValue
Enrollment Target 1,267 participants
Start Date 2007-05
Est. Completion 2012-11
Phase NA

What the finished NCT00375024 record still lists

NCT00375024 is an interventional study that assigns participants to a tested intervention. Its 1,267 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (55% lower).

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Patient Navigation is the first listed.

NCT00375024 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT00375024 about?

NCT00375024 is a clinical study titled "Patient Navigator Project". Patient Navigation is a Supportive Care Intervention that addresses barriers to quality standard care by providing individualized assistance to patients and families. The NCI is conducting several research programs to test the effectiveness of this approach. The expected outcomes of patient navigati...

What is the current status of trial NCT00375024?

This trial is currently completed. It is a NA study. The enrollment target is 1,267 participants. The study started on 2007-05. Estimated completion is 2012-11.

What conditions does trial NCT00375024 study?

This clinical trial studies the following conditions: Breast Cancer, Colon Cancer.

What interventions are being tested in trial NCT00375024?

The interventions under investigation include: Patient Navigation (PROCEDURE), Clinic Staff (PROCEDURE).

Who is sponsoring clinical trial NCT00375024?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00375024 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00375024's enrollment target sits among peer trials

1,267 97th of 1224 higher than 1,128 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06790641 · 1,270 participants · NA

    Pathways to Perinatal Mental Health Equity

  • NCT06876246 · 1,270 participants · NA

    SBIR/ STTR Family Check-up Online

  • NCT06119581 · 1,264 participants · Phase 3

    A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • NCT03678025 · 1,273 participants · Phase 3

    Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00375024, the US trial registry maintained by the National Library of Medicine. NCT00375024 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.